ASPIRE BIOPHARMA HLDGS INC COM
ASPIRE BIOPHARMA HLDGS INC COM is a security (CUSIP 738920206) tracked across SEC portfolio filings. 6 institutional managers reported $329K on Form 13F as of 2026-03-31; 2 registered fund positions totaling $8K via N-PORT as of 2026-03-31.
Summary
- Issuer: ASPIRE BIOPHARMA HLDGS INC
- Class: COM
- CUSIP: 738920206
- Asset category: EC
- 13F holders: 6
- 13F value: $329K
- 13F period: 2026-03-31
- N-PORT fund positions: 2
- N-PORT value: $8K
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| UBS Group AG | Zurich, V8 | $197K | 191,499 |
| MORGAN STANLEY | NEW YORK, NY | $79K | 76,955 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $45K | 43,384 |
| TORONTO DOMINION BANK | Toronto, Ontario, A6 | $5K | 5,000 |
| Tower Research Capital LLC (TRC) | NEW YORK, NY | $2K | 2,174 |
| OSAIC HOLDINGS, INC. | PHOENIX, AZ | $2 | 2 |
Top fund holders (N-PORT)
More